Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Duangporn Saengwimol"'
Autor:
Pamorn Chittavanich, Duangporn Saengwimol, Sittiruk Roytrakul, Duangnate Rojanaporn, Vijender Chaitankar, Atthapol Srimongkol, Usanarat Anurathapan, Suradej Hongeng, Rossukon Kaewkhaw
Publikováno v:
Molecular Oncology, Vol 18, Iss 4, Pp 918-938 (2024)
MYCN proto‐oncogene, bHLH transcription factor (MYCN) amplification is associated with aggressive retinoblastoma (RB) and neuroblastoma (NB) cancer recurrence that is resistant to chemotherapies. Therefore, there is an urgent need to identify new t
Externí odkaz:
https://doaj.org/article/838f6bba7dd247d2ac55f67737ffd727
Autor:
Pamorn Chittavanich, Duangporn Saengwimol, Ariestya Indah Permata Sari, Atthapol Srimongkol, Rossukon Kaewkhaw
Publikováno v:
STAR Protocols, Vol 5, Iss 4, Pp 103377- (2024)
Summary: MYCN amplification is a hallmark of aggressive neuroblastoma, driving N-Myc overexpression and enhancing protein synthesis, making these processes potential therapeutic targets. Here, we present a protocol for quantifying nascent N-Myc and g
Externí odkaz:
https://doaj.org/article/e85952b636314204bce07191d5c52846
Autor:
Atthapol Srimongkol, Natanan Laosillapacharoen, Duangporn Saengwimol, Vijender Chaitankar, Duangnate Rojanaporn, Thanastha Thanomchard, Suparerk Borwornpinyo, Suradej Hongeng, Rossukon Kaewkhaw
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 42, Iss 1, Pp 1-15 (2023)
Abstract Background Recurrence of retinoblastoma (RB) following chemoreduction is common and is often managed with local (intra-arterial/intravitreal) chemotherapy. However, some tumors are resistant to even local administration of maximum feasible d
Externí odkaz:
https://doaj.org/article/cb4c8e3df194403984b3b4e33686fb93
Autor:
Duangporn Saengwimol, Duangnate Rojanaporn, Vijender Chaitankar, Pamorn Chittavanich, Rangsima Aroonroch, Tatpong Boontawon, Weerin Thammachote, Natini Jinawath, Suradej Hongeng, Rossukon Kaewkhaw
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-13 (2018)
Abstract Persistent or recurrent retinoblastoma (RB) is associated with the presence of vitreous or/and subretinal seeds in advanced RB and represents a major cause of therapeutic failure. This necessitates the development of novel therapies and thus
Externí odkaz:
https://doaj.org/article/7055f181010d4848b2eaf2b999543e4e
Autor:
Thanik Chokjirawat, Mutchuporn Sukpresert, Wicharn Choktanasiri, Wanwisa Waiyaput, Duangporn Saengwimol, Aruchalean Taweewongsounton, Tanjitti Pongrujikorn, Chonthicha Satirapod
Publikováno v:
Journal of Human Reproductive Sciences, Vol 11, Iss 1, Pp 52-58 (2018)
Aims: The aim is to study the relation and distribution in gene expression level of the luteinizing hormone receptor (LHR) gene and regulator of G-protein signaling 2 (RGS2) gene expression with oocyte maturation. Setting and Design: This cross-secti
Externí odkaz:
https://doaj.org/article/b3d3625044764df3b9f1e26f9baf9d79
Autor:
Tanjitti Pongrujikorn, Wicharn Choktanasiri, Aruchalean Taweewongsounton, Wanwisa Waiyaput, Duangporn Saengwimol, Mutchuporn Sukpresert, Thanik Chokjirawat, Chonthicha Satirapod
Publikováno v:
Journal of Human Reproductive Sciences
Journal of Human Reproductive Sciences, Vol 11, Iss 1, Pp 52-58 (2018)
Journal of Human Reproductive Sciences, Vol 11, Iss 1, Pp 52-58 (2018)
Aims: The aim is to study the relation and distribution in gene expression level of the luteinizing hormone receptor (LHR) gene and regulator of G-protein signaling 2 (RGS2) gene expression with oocyte maturation. Setting and Design: This cross-secti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a86340f85c7565d2f8cf4a318e5edb4
http://europepmc.org/articles/PMC5892105
http://europepmc.org/articles/PMC5892105
Publikováno v:
BioMed Research International
BioMed Research International, Vol 2019 (2019)
BioMed Research International, Vol 2019 (2019)
Background. Noncultured epidermal suspension (NCES) is a surgical technique which employs cellular grafting onto depigmented lesions. However, scarring and dyschromia at the donor site often occurs. Objective. To assess the outcome of reusing the sam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67a34cef39049c9429620cd4dc0dbbab
Autor:
Duangporn Saengwimol, Bhoom Suktitipat, Natanan Laosillapacharoen, Pamorn Chittavanich, Suradej Hongeng, Vijender Chaitankar, Duangnate Rojanaporn, Atthapol Srimongkol, Rossukon Kaewkhaw, Saovaros Svasti, Rangsima Aroonroch, Chonticha Saisawang
Publikováno v:
Investigative Ophthalmology & Visual Science
Purpose MYCNOS (MYCN opposite strand) is co-amplified with MYCN in pediatric cancers, including retinoblastoma. MYCNOS encodes several RNA variants whose functions have not been elucidated in retinoblastoma. Thus, we attempted to identify MYCNOS vari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ca096b1c44c8839f0c802bac6366113
https://doi.org/10.1167/iovs.61.14.8
https://doi.org/10.1167/iovs.61.14.8
Autor:
Tatpong Boontawon, Vijender Chaitankar, Natini Jinawath, Duangporn Saengwimol, Suradej Hongeng, Pamorn Chittavanich, Weerin Thammachote, Rossukon Kaewkhaw, Rangsima Aroonroch, Duangnate Rojanaporn
Publikováno v:
Scientific Reports
Scientific Reports, Vol 8, Iss 1, Pp 1-13 (2018)
Scientific Reports, Vol 8, Iss 1, Pp 1-13 (2018)
Persistent or recurrent retinoblastoma (RB) is associated with the presence of vitreous or/and subretinal seeds in advanced RB and represents a major cause of therapeutic failure. This necessitates the development of novel therapies and thus requires
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::865dff553d03f2e66f12e0ad8065e86d
https://pubmed.ncbi.nlm.nih.gov/30353124
https://pubmed.ncbi.nlm.nih.gov/30353124
Autor:
Srimongkol, Atthapol1 (AUTHOR), Laosillapacharoen, Natanan2 (AUTHOR), Saengwimol, Duangporn1 (AUTHOR), Chaitankar, Vijender3 (AUTHOR), Rojanaporn, Duangnate4 (AUTHOR), Thanomchard, Thanastha5 (AUTHOR), Borwornpinyo, Suparerk6,7 (AUTHOR), Hongeng, Suradej8 (AUTHOR), Kaewkhaw, Rossukon2,9 (AUTHOR) rossukon.kae@mahidol.edu
Publikováno v:
Journal of Experimental & Clinical Cancer Research (17569966). 2/1/2023, Vol. 42 Issue 1, p1-15. 15p.